Skip Navigation
 
Home | About CDC | Media Relations | A-Z Index | Contact Us
   
Centers for Disease Control & Prevention
CDC en Español 
Sexually Transmitted Diseases
Sexually Transmitted Diseases  >  Program Guidelines  >  Medical and Laboratory Services

Medical and Laboratory ServicesProgram Operations Guidelines for STD Prevention
Medical and Laboratory Services

Appendix ML-E

Commonly Used Stat Tests—Useful Tips

RPR CARD TEST

Test Principles

The rapid plasma reagin (RPR) 18-mm circle card test is a macroscopic, nontreponemal flocculation card test used to screen for syphilis (Creighton, 1990). The antigen is prepared from a modified Venereal Disease Research Laboratory (VDRL) antigen suspension containing choline chloride to eliminate the need for heat inactivation of serum, ethylenediaminetetraacetic acid (EDTA) to enhance the stability of the suspension, and finely divided charcoal particles as a visualizing agent. For the test, the RPR antigen is mixed with unheated or heated serum or with unheated plasma on a plastic-coated card. The RPR test measures antibodies to lipoidal material released from damaged host cells as well as to lipoprotein-like material, and possibly cardiolipin released from the treponemes. If antibodies are present, they combine with the lipid particles of the antigen, causing them to agglutinate or clump. The charcoal particles coagglutinate with the antibodies and show up as black clumps against the white card. If antibodies are not present, the test mixture is uniformly gray. Without some other evidence for the diagnosis of syphilis, a reactive nontreponemal test does not confirm T. pallidum infection.

Specimen Collection

Serum—Collect whole blood into a clean, dry tube without an anticoagulant.

Plasma—Collect blood in a tube containing EDTA as an anticoagulant. Completely fill the tube or collect blood until the vacuum in the collection tube has been exhausted.

Label each specimen with patient identifier, and date.

Procedure

Qualitative Test

  1. To prepare antigen for testing, attach the hub of the dispensing needle to the fitting on the plastic dispensing bottle. Shake the antigen ampule to resuspend the particles. Open the ampule. Squeeze the dispensing bottle to collapse it. Insert the needle into the ampule and withdraw all the antigen suspension into the dispensing bottle.
  2. Place serum or plasma onto a 18-mm circle of the RPR test card, using a disposable Dispenstir or a safety pipetting device.
  3. Using the inverted Dispenstir (closed end) or flat toothpicks, spread the serum or plasma to fill the entire circle. Do not spread the specimen beyond the confines of the circle.
  4. Gently shake the antigen dispensing bottle to resuspend the particles.
  5. Holding the dispensing bottle and needle in a vertical position, dispense several drops to clear the needle of air. Then add antigen suspension to each circle containing serum or plasma. Do not mix.
  6. Place the card on the mechanical rotator under a humidifying cover. Rotate the card.
  7. Immediately remove the card from the rotator; briefly rotate and tilt the card by hand to aid in differentiating nonreactive from minimally reactive results.
  8. Perform the quantitative test on serum specimens showing any degree of reactivity (clumping) or "roughness."

Reading and Reporting of Qualitative Results

  1. Read the test reactions in the "wet" state under a high-intensity incandescent lamp. Read the test without magnification.
  2. Report the results as follows:
Reading Report
Characteristic clumping ranging from marked and intense (reactive) to slight but definite (minimally to moderately) reactive Reactive (R)
Slight roughness or no clumping Nonreactive (N)

Note: Only two reports with the RPR card test are possible: Reactive, no matter how much clumping, or Nonreactive.

Interpretation of Results

  1. The RPR card test is an aid in the diagnosis of syphilis. Clinicians combine the RPR card test with results of other serologic tests, darkfield examinations, clinical signs and symptoms, and risk factors in arriving at a syphilis diagnosis. Without some other support for the diagnosis of syphilis, a reactive RPR card test is commonly unrelated to Treponema pallidum infection. The predictive value of a reactive RPR card test in a serologic diagnosis of syphilis is increased when combined with a reactive treponemal test, such as the fluorescent treponemal antibody absorption (FTA-ABS) test.
  2. A reactive RPR card test may suggest past or present infection with a pathogenic treponeme; however, it may also be a false-positive reaction. False-positive reactions can result from laboratory error as well as serum antibodies unrelated to syphilis infection. Technical errors are detected by a nonreactive RPR card test with a second serum specimen. False-positive RPR card tests from infections with nontreponemal diseases or other disease conditions are identified by an accompanying nonreactive treponemal test.
  3. A nonreactive RPR card test without clinical evidence of syphilis may suggest no current infection or an effectively treated infection. A nonreactive RPR card test with clinical evidence of syphilis can be seen in early primary syphilis; in secondary syphilis, as a result of the prozone reaction (see test limitations); and in some cases of late syphilis. A nonreactive RPR card test result does not rule out an incubating syphilis infection.
  4. When the quantitative RPR card test is performed on patients with syphilis, a fourfold rise in titer on a repeat specimen may suggest an infection, a reinfection, or a treatment failure; a fourfold decrease in titer in early syphilis usually indicates adequate syphilis therapy.
  5. All reactive qualitative RPR card tests should be diluted to an endpoint and the endpoint titer reported.

Sources of Error

  1. If the temperatures of the sera, reagents, or testing area are less than 23%C (73%F), test reactivity decreases; if temperatures are greater than 29%C (85%F), test reactivity increases.
  2. If the speed of the mechanical rotator is too fast or too slow, improper antigen-antibody interaction will cause unpredictable test results.
  3. If the time of rotation is too long test reactivity may be increased, or if too short test reactivity may be decreased.
  4. If the card is excessively rotated and tilted (to-and fro motions) by hand after removal from the rotator, a false- reactive result may occur.
  5. If lighting produces a glare on the card, the reactions may be obscured.
  6. If the antigen is outdated or not adequately tested for standard reactivity, the results may be unpredictable.
  7. If the serum is unevenly spread in the circle, the antigen and antibody may not mix properly.
  8. If hemolyzed, contaminated, or improperly collected serum or plasma samples are tested, the reaction may be masked.
  9. If the moistened humidifying cover is not used to cover tests as they are being rotated, proper humidity will not be maintained, and test components may dry on card, and false reactive results may occur.

Test Limitations

  1. The RPR card test cannot be used to test spinal fluids.
  2. A prozone reaction may be encountered occasionally. In a prozone reaction, complete or partial inhibition of reactivity occurs with undiluted serum (maximum reactivity is obtained only with diluted serum). The prozone phenomenon may be so pronounced that only a rough reading is produced in the qualitative test by a serum that will be strongly reactive when diluted. All test specimens producing any degree of roughness or reactivity with the RPR card test antigen in the qualitative test should be retested by using the quantitative procedure.
  3. The RPR card test may be reactive in persons from countries where yaws, pinta or nonvenereal syphilis is endemic. Generally, residual titers from these infections will be no higher than 1:4.
  4. Biological false-positive (BFP) reactions occur occasionally with cardiolipin antigens, mainly in specimens from persons who abuse drugs; who have diseases such as lupus erythematosus, mononucleosis, malaria, leprosy, or viral pneumonia; or who have recently been vaccinated.
  5. Nontreponemal test titers of persons who have been treated in latent or late stages of syphilis or who have become reinfected do not decrease as rapidly as do those of the persons in the early stages of their first infection. In fact, these individuals may remain "serofast," retaining a low-level reactive titer for life.




Page last modified: August 16, 2007
Page last reviewed: August 16, 2007 Historical Document

Content Source: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention